معرفی
Elham Khatamzas is a Clinical Professor and Senior Physician in the Department of Infectious and Tropical Medicine at Heidelberg University Hospital (UKHD). She holds academic and clinical roles, including Deputy positions, and specializes in infectious diseases, microbiology, and virology. Her career includes roles at Oxford University Hospital NHS Trust, Charité Berlin, and the University of Oxford (PhD 2012). She has led clinical trials (e.g., OVIVA trial on antibiotic efficacy) and contributed to global health initiatives, such as improving fungal care standards in Brazil. Her research focuses on antimicrobial therapy, fungal infections, and post-COVID complications. Notable work includes studies on nivolumab in fusariosis and rezafungin in candidemia, emphasizing translational and clinical research. She advocates for equity in academia and publishes in high-impact journals like the New England Journal of Medicine and European Journal of Cancer.
